Skin Boosters for Melasma and Sun-Damaged Skin: Cellular Repair Protocols

Skin boosters for melasma and sun-damaged skin are injectable or biorevitalisation treatments designed to deliver hydrating, regenerative, and antioxidant-rich compounds directly into the dermis. They aim to support cellular repair, improve skin quality, and address the underlying conditions that contribute to pigmentation irregularity and photodamage, rather than simply treating visible surface symptoms.

Before exploring treatment options, it is helpful to understand what distinguishes melasma from other forms of pigmentation and why sun-damaged skin presents its own clinical complexities.

Melasma is a chronic pigmentation condition characterised by symmetrical patches of brown or grey-brown discolouration, most commonly appearing on the cheeks, forehead, upper lip, and chin. It is closely associated with hormonal fluctuations — including those triggered by pregnancy, contraceptive use, or hormonal therapies — and is significantly worsened by UV exposure. Melasma is considered a challenging condition to manage because it tends to recur and can be sensitive to certain treatments that generate heat or inflammation.

Sun-damaged skin, also referred to as photodamage or photoageing, encompasses a broader range of concerns including uneven tone, solar lentigines (commonly called sunspots or age spots), reduced skin elasticity, fine lines, and a generally dulled complexion. These changes result from cumulative exposure to ultraviolet radiation over time, which damages DNA within skin cells, degrades collagen and elastin fibres, and triggers irregular melanin production.

Both conditions involve disrupted skin cell behaviour at a biological level, which is why cellular-level interventions such as skin boosters are of increasing interest in aesthetic medicine.

To understand why skin boosters may be relevant to melasma and photodamaged skin, it is important to appreciate what happens within the skin at a cellular level when UV damage or hormonal triggers are present.

The skin's primary pigment-producing cells are called melanocytes, located in the basal layer of the epidermis. When stimulated by UV radiation, inflammation, or hormonal signals, melanocytes produce excess melanin, which is distributed unevenly into surrounding keratinocytes. Over time, this results in visible patches or spots of darkened skin.

Meanwhile, UV exposure also damages the extracellular matrix — the structural scaffold of the skin — by degrading collagen and elastin fibres through a process involving matrix metalloproteinases (MMPs). The skin's antioxidant defences become overwhelmed, increasing oxidative stress, which in turn accelerates visible ageing.

Skin booster formulations are designed to intervene in several of these processes simultaneously. Depending on their composition, they may deliver:

Hyaluronic acid — to restore deep hydration and support the extracellular matrix

Polynucleotides (PDRN/PN) — to stimulate tissue regeneration and support DNA repair mechanisms

Antioxidants such as glutathione, vitamin C, or amino acid complexes — to reduce oxidative stress and support a more even melanin distribution

Growth factors or peptides — to encourage cellular renewal and collagen synthesis

By addressing the dermal environment at this level, the aim is to support the skin's own repair capacity rather than simply bleaching or exfoliating the surface.

Not all skin boosters are formulated equally, and the approach used for melasma or sun-damaged skin may differ from protocols designed purely for hydration or anti-ageing.

Hyaluronic acid-based skin boosters — such as those in the Restylane Skinboosters or Juvederm Volite family — are well-established for improving overall skin quality, hydration, and radiance. While not specifically pigmentation-targeting agents, improved dermal hydration can support the skin's resilience and reduce the inflammatory triggers that worsen melasma.

Polynucleotide (PN or PDRN) treatments — derived from purified salmon or trout DNA — are increasingly used in cellular repair contexts. Research suggests polynucleotides may support tissue regeneration, reduce inflammation, and contribute to a healthier dermal environment. Their anti-inflammatory properties may be particularly relevant in melasma, where chronic low-grade inflammation plays a role in pigment activation. You can read more about polynucleotide skin treatments at Pantaleo Clinic to understand how these formulations are used in practice.

Brightening biorevitalisation cocktails — proprietary combinations of amino acids, vitamins, antioxidants, and sometimes low concentrations of depigmenting agents — are used in some clinical protocols to address pigmentation more directly.

A qualified practitioner will assess which formulation or combination protocol is most appropriate based on individual skin assessment.

In clinical practice, a skin booster protocol for melasma or sun-damaged skin is rarely a single-session intervention. Most practitioners design a course of treatments to achieve gradual, cumulative improvement aligned with the skin's natural regenerative cycles.

A typical protocol may include:

Initial consultation and skin assessment — including a detailed discussion of medical history, hormonal factors, medication use, and prior treatments, as these directly affect suitability and treatment design

A course of 3–4 treatment sessions — usually spaced 2–4 weeks apart during an initial phase

Maintenance sessions — typically once every 3–6 months, depending on individual skin response

Adjunctive home skincare — practitioners commonly recommend medical-grade SPF, vitamin C serums, retinoids, or other active ingredients to support and extend treatment outcomes

The technique of administration may vary — microinjections, microneedling-assisted delivery, or topical application with physical enhancement — depending on the product used and the practitioner's clinical judgement.

It is important to note that melasma in particular requires careful treatment selection, as certain energy-based or heat-generating treatments can paradoxically worsen pigmentation. A practitioner experienced in pigmentation management will be aware of these considerations.

Skin boosters may be a consideration for patients who are experiencing:

Persistent melasma that has not responded adequately to topical treatments alone

Visible photodamage including uneven skin tone, solar lentigines, or a generally dull complexion

Concerns about skin quality, texture, and radiance alongside pigmentation irregularity

A preference for a regenerative approach that works with the skin's biology rather than aggressive surface treatments

However, suitability depends heavily on individual circumstances. Treatment may not be appropriate — or may require modification — for patients who:

Are pregnant or breastfeeding

Have active skin infections or inflammatory skin conditions at the treatment site

Are taking medications such as anticoagulants that increase bleeding risk

Have a history of severe allergic reactions or hypersensitivity to treatment components

Have previously had adverse reactions to injectable aesthetic treatments

Melasma is a condition with a tendency to recur, and patients should have realistic expectations about long-term management rather than expecting a permanent resolution after a single course of treatment. This is a conversation best had during a thorough professional consultation, where individual history, skin type, and treatment goals can be properly explored.

It is important that patients considering any aesthetic treatment approach this with balanced expectations. Skin boosters can offer meaningful improvements in skin quality when used appropriately, but they are not cure-all solutions.

Potential benefits that practitioners observe may include:

Improved skin hydration and luminosity

Gradual softening of superficial pigmentation irregularity over a course of treatments

Enhanced skin texture and smoothness

A more resilient dermal environment that may reduce the severity of future photodamage

Reduced dullness and improved overall skin tone

Realistic limitations to be aware of:

Results vary considerably between individuals based on skin type, Fitzpatrick classification, hormonal status, and lifestyle factors

Melasma, in particular, can be unpredictable and may recur without ongoing maintenance and diligent sun protection

Deeper or long-standing pigmentation may respond more slowly or require combination approaches

No injectable treatment can replicate the results of comprehensive sun avoidance

Multiple sessions are typically required before meaningful results become visible

Patients with darker skin tones (Fitzpatrick types IV–VI) require particularly careful practitioner assessment, as certain treatments can trigger post-inflammatory hyperpigmentation if not selected and administered appropriately.

Aftercare following skin booster treatments plays an important role in both the safety and the quality of outcomes. General guidance following injectable skin booster sessions may include:

Avoiding sun exposure for at least 48–72 hours post-treatment, and ideally longer where possible

Applying broad-spectrum SPF 50 sunscreen daily — this is not optional for patients with melasma or photodamage; consistent sun protection is arguably the most important factor in managing both conditions long-term

Avoiding intense heat including saunas, steam rooms, and strenuous exercise for 24–48 hours

Keeping the skin well hydrated using gentle, non-irritating moisturisers

Avoiding active skincare ingredients such as retinoids or exfoliating acids for a short period post-treatment, as advised by your practitioner

Following any specific aftercare instructions provided by your treating clinician, as guidance may vary depending on the product used and the technique applied

A home skincare routine designed to support your treatment — ideally incorporating antioxidant serums, a gentle cleanser, and daily SPF — is something many practitioners recommend as an integral part of the protocol rather than an afterthought. For patients interested in exploring broader skin rejuvenation options at Pantaleo Clinic, a consultation can help identify which combination of in-clinic and at-home approaches may be most appropriate.

If you are managing melasma or sun-damaged skin and are considering whether aesthetic skin treatments might form part of your skin health strategy, a professional assessment with a qualified practitioner is the appropriate first step. This is particularly relevant if you:

Have been using topical treatments for some time without achieving the improvement you were hoping for

Are uncertain whether your pigmentation is melasma, post-inflammatory hyperpigmentation, or another condition — as these require different management approaches

Have questions about how treatments interact with your skin type, hormonal history, or current skincare routine

Are considering combining skin booster treatments with other modalities such as chemical peels or laser treatments and want to understand sequencing and safety

Have simply not had an expert review your skin and would like informed guidance on an appropriate pathway

A consultation is a low-pressure opportunity to discuss your concerns, ask questions, and receive an honest assessment of what treatment options may — and may not — be suitable for your individual situation. You can book a consultation at Pantaleo Clinic to speak with an experienced practitioner about your skin health goals.

Skin boosters for melasma and sun-damaged skin work at a cellular level, aiming to support hydration, tissue repair, and a healthier dermal environment rather than simply targeting surface pigmentation

Melasma is a complex, often recurring condition that requires careful treatment selection — some treatments can worsen pigmentation if not chosen appropriately

A course of treatments over several weeks is typically required, with maintenance sessions recommended for sustained results

Daily broad-spectrum sun protection is essential — no aesthetic treatment can compensate for continued unprotected UV exposure

Individual results vary based on skin type, hormonal factors, lifestyle, and treatment compliance; realistic expectations are important

Professional assessment is essential before beginning any treatment, to determine suitability, identify contraindications, and design an appropriate protocol

Skin boosters for melasma and sun-damaged skin represent an evidence-informed area of aesthetic medicine that continues to evolve as understanding of cellular repair mechanisms deepens. For patients who have experienced the frustration of pigmentation concerns that feel resistant to topical skincare alone, these protocols offer a clinically considered approach to supporting the skin's own regenerative capacity from within the dermis.

As this article has outlined, the most important principles underpinning successful outcomes in this context are: careful practitioner selection, an accurate diagnosis of the type and cause of pigmentation present, a realistic understanding of what these treatments can and cannot achieve, and an unwavering commitment to daily sun protection regardless of which treatment pathway is chosen.

Melasma and photodamage are long-term skin health considerations rather than problems that can be permanently resolved through a single course of aesthetic treatment. A thoughtful, protocol-based approach, designed individually and reviewed over time, is the most responsible framework for managing these conditions.

Treatment suitability, risks, and expected outcomes should always be assessed individually during a professional consultation.

If you are researching skin booster treatments for melasma or sun-damaged skin and would like to discuss your concerns with a qualified practitioner, speaking with a clinician who specialises in skin health and aesthetic medicine is an important first step toward informed decision-making.